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Placental mesenchymal stem cells (PMSCs) are multipotent cells that can diﬀerentiate in vitro to multiple lineages, including
bone. Insulin-like growth factors (IGFs, IGF-1 and IGF-2) participate in maintaining growth, survival, and diﬀerentiation of
many stem cells, including osteoprogenitors. Low oxygen tension (PO2) can maintain stem cell multipotency and impede
osteogenic diﬀerentiation. In this study, we investigated whether PMSC osteogenic diﬀerentiation is inﬂuenced by low PO2
and by IGFs. Our results indicated that low PO2 decreased osteogenic markers RUNX2 and OPN; however, re-exposure to
higher oxygen tension (room air) restored diﬀerentiation. IGFs, especially IGF-1, triggered an earlier expression of RUNX2
and enhanced OPN and mineralization. RUNX2 was phosphorylated in room air and augmented by IGFs. IGF-1 receptor
(IGF-1R) was increased in low PO2 and reduced by IGFs, while insulin receptor (IR) was increased in diﬀerentiating PMSCs
and enhanced by IGF-1. Low PO2 and IGFs maintained higher IR-A which was switched to IR-B in room air. PI3K/AKT was
required for osteogenic diﬀerentiation, while MEK/ERK was required to repress an RUNX2 and OPN increase in low PO2.
Therefore, IGFs, speciﬁcally IGF-1, trigger the earlier onset of osteogenic diﬀerentiation in room air, whereas, reversibly, low
PO2 impedes complete diﬀerentiation by maintaining higher multipotency and lower diﬀerentiation markers.
1. Introduction
Mesenchymal stem cells (MSCs), found in many adult tis-
sues, are responsible for tissue repair and regeneration after
injury or disease [1]. Unlike embryonic stem cells (ESCs),
MSCs are less tumorigenic and have a more restricted mesen-
dodermal lineage-speciﬁc diﬀerentiation towards myocytes,
osteoblasts, chondrocytes, adipocytes, stromal ﬁbroblasts,
and endothelial cells [1–4]. Also, MSCs can modulate the
immune response and have been used successfully in graft-
versus-host disease-resistant patients [5]. Therefore, MSCs
are promising candidates for stem cell-based therapies to
treat many adult and paediatric diseases, such as sickle cell
disease [6], rheumatic diseases [7], lymphoma [8], and heart
failure [9]. In bone, MSC transplantation has been used to
correct bone malformation and injury. In children, osteogen-
esis imperfecta (OI) is a severe genetic disorder of mesenchy-
mal cells with a deﬁcit for type I collagen which is important
for matrix deposition and mineralization [10]. There is no
treatment for OI; however, an allogeneic bone marrow trans-
plantation has been shown to successfully accelerate linear
growth and increase total body bone mineral density in OI
children [10].
Although bone marrow MSCs were used for stem cell
therapy [11, 12], placental MSCs (PMSCs) are abundant
and readily available and do not require invasive techniques
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for isolation [13]. PMSCs are isolated from diﬀerent com-
partments of the placenta (the amnion, the chorion, and
the fetal membranes) and have a higher proliferation capac-
ity than bone marrow MSCs [13]. MSCs are dependent on
their surrounding microenvironment for maintaining stem
cell identity [14, 15], and they diﬀerentiate by speciﬁc pro-
moting factors via a tight transcriptional network signaling
loss of multipotency and initiating linage-speciﬁc progenitor
diﬀerentiation. In osteoblast diﬀerentiation, runt-related
transcription factor 2 (RUNX2) is the initiation transcription
factor that upregulates transcription of genes required for
bone matrix deposition and mineralization including
osteopontin (OPN), osteocalcin (OCN), type I collagen, and
alkaline phosphatase [16–19]. RUNX2 is phosphorylated
by the mitogen-activated protein kinase (MAPK) at the
C-terminal proline-serine-threonine (PST) region, which
is required for its transcriptional activity and DNA binding
to promoter regions of osteogenic genes, such as OPN and
OCN [20, 21].
Stem cell diﬀerentiation condition is controlled by solu-
ble factors, small molecules, hormones, and growth factors
[15]. The insulin-like growth factors (IGFs, IGF-1 and
IGF-2) can promote and stimulate stem cell diﬀerentiation
towards several lineages from all three germ layers [22–26],
including osteoblast diﬀerentiation [27] and in vivo bone
development [28, 29]. IGF-1 and IGF-2 and their receptor
IGF-1R have a strong association with osteogenesis and are
abundantly expressed speciﬁcally in mature osteoblasts and
osteoclasts in autocrine/endocrine mechanism [27]. IGF-1-
and IGF-1R-null mice show underdeveloped short bone,
low bone mineral density, and delayed calciﬁcation, whereas
IGF-2-null mice show no major skeletal defects [28].
Therefore, IGF-1 and IGF-2 may have distinct functions
in osteogenic diﬀerentiation.
In vivo, hypoxia-inducible fator-1α- (HIF1α-) knockout
mice have decreased trabecular bone volume, reduced bone
formation rate, and reduced proliferation of osteoblasts
during long bone development [30]. In contrast, an over-
expression of HIF1α in osteoblasts leads to the develop-
ment of extremely dense and heavily vascularized long
bones [31]. Therefore, low oxygen tension, which stabilizes
HIF1α, is required for gene regulation required for healthy
bone development. In vitro, low oxygen tension promotes
stem cell proliferation, self-renewal, and multipotency [32]
but inhibits osteoblast diﬀerentiation [33]. However, re-
exposure to room air restores complete diﬀerentiation and
may potentiate osteogenic diﬀerentiation [34, 35]. Hence,
long-term exposure to low oxygen tension is inhibitory to
stem cell diﬀerentiation, whereas a short-term exposure can
play a role in directing stem cell fate towards a more robust
osteogenic diﬀerentiation [34].
IGFs and low oxygen tension are natural niche compo-
nents of osteogenic microenvironment, which are shown to
aﬀect later stages of osteogenic diﬀerentiation during the
mineralization period of MSC diﬀerentiation [36, 37]. How-
ever, the combined eﬀect of these two microenvironmental
factors on the commitment and early diﬀerentiation stages
is not clear. In this study, we used preterm PMSCs to study
the role of IGF-1 and IGF-2 signaling in combination with
low oxygen tension in osteogenic diﬀerentiation. We show
that low oxygen tension inhibits PMSC osteogenic diﬀerenti-
ation, and IGF-1 more than IGF-2 enhances diﬀerentiation
via speciﬁc signaling pathways mediated via IGF-1R/IR,
PI3K, MEK1/2, and RUNX2 phosphorylation.
2. Material and Methods
2.1. PMSC Isolation. PMSCs were isolated from early gesta-
tion (10–13 weeks) human placentae. After informed consent
was taken, placentae were collected from patients who under-
went therapeutic pregnancy termination. Immediately after
surgery, placentae were dissected under sterile conditions
and small pieces of chorionic villi were collected. Tissue sam-
ples were minced mechanically and subjected to a process
consisting of two steps of enzymatic digestion with (1) colla-
genase IV/hyaluronidase and (2) DNase I followed by (3)
trypsin/EDTA. Each enzymatic step was performed for
20min at 37°C, followed by 10min wash at 4°C in a solution
of PBS supplemented with 10% fetal bovine serum (FBS)
(Gibco, Mississauga, ON). Cells released during digestion
were passed through a tissue mesh (45μm) to obtain a single
cell suspension. Next, cells were separated on a Percoll
(Sigma) discontinuous gradient according to a modiﬁed
protocol by Worton et al. for hematopoietic stem cell
isolation [38] and then seeded in DMEM/F12 media (Gibco,
Mississauga,ON) supplementedwith 10%FBS and antibiotic-
antimycotic solution. After 4 days, media was changed and
nonadherent cells were washed with media to leave behind
adherent PMSCs forming colonies. PMSC colonies were
characterized by ﬂow cytometry for presence/absence of cell
surface markers CD90, CD73, CD105, and CD117/c-kit as
published previously [39].
2.2. Osteogenic Diﬀerentiation and Incubation in Low Oxygen
Tension. Cells were cultured and maintained using DMEM/
F12 media supplemented with 10% ES-FBS and FGF-2
(100 ng/mL) (Gibco, Mississauga, ON). Before treatments,
cells were cultured in DMEM/F12 supplemented with 10%
FBS only. Upon treatment, PMSCs were plated at 70%
conﬂuency in nondiﬀerentiation conditions (15% FBS/
DMEMF12) or in the presence of osteogenic stimulatory
conditions (15% osteogenic diﬀerentiation FBS, 10−8M
dexamethasone, 50μg/mL ascorbic acid, and 3.5mM β-
glycerophosphate) (STEMCELL Technologies, Vancouver,
BC). For IGF-1 or IGF-2 treatments, 100 ng/mL of either
IGF was added to a reduced FBS level of basic 2% osteo-
genic diﬀerentiation media; IGFs were added fresh at every
media change. The relative eﬀect of diﬀerent IGF and oxy-
gen tension treatments on calcium deposits was compared
using alizarin red and alkaline phosphatase staining. The
signaling of the MEK/ERK pathway or the PI3K/AKT path-
ways was inhibited by the continuous presence of U0126
(5μM) or LY294002 (10μM), respectively. Cell cultures
were then placed in either a 5% CO2 incubator or a hypoxia
chamber, which was ﬁlled with a mix of 1% O2, 5% CO2,
and balanced N2 (BOC Canada Ltd., Toronto, ON) for
15min to ensure saturation using a Hudson 5590 Oxygen
Monitor (Hudson, Ventronics Division, Temecula, CA).
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Thereafter, the chamber was placed in a tissue culture incu-
bator at 37°C.
2.3. Alizarin Red Staining and Quantiﬁcation. To assess these
morphological changes in diﬀerentiated versus nondiﬀeren-
tiated cells, cells were cultured for 14 days and then ﬁxed with
4% formaldehyde for 30min at RT. Then, cells were stained
either with 1% alizarin red solution for 10min at RT or
with NBT/BCIP reagent (Vector Labs, Burlington, ON) as
per the manufacturer’s protocol. Both stainings were then
solubilized with 10% cetylpyridinium chloride in 10mM
sodium phosphate buﬀer (pH7.0) as previously described
[27]. The absorbance of 200μL solubilized staining was read
at λ=570 nm using a plate reader. The absorbance was then
normalized to total protein content per well in micrograms.
2.4. RT-PCR for Insulin Receptor Isoforms in PMSCs. Total
RNA was extracted from diﬀerentiated and nondiﬀeren-
tiated PMSCs using the PureLink RNA Mini Kit (Ambion,
Burlington, ON) as per the manufacturer’s protocol. 1–3μg
total RNA was reverse-transcribed using the Superscript III
First-Strand Synthesis System for RT-PCR (Invitrogen,
Burlington, ON) and oligo (dT)20 primers. End-point PCR
reactions were run in 25μL using the Eppendorf 96-well
plate thermocycler. Human IR isoforms in the same cDNA
sample were detected using primers amplifying exon 11
including IR-B (250 bp) or excluding IR-A (214 bp) and
ampliﬁed as published previously [40]. Human RPL13a
levels were used as the reference endogenous control for nor-
malization of the target mRNAs. Ampliﬁcation conditions
were run at 92°C for 5min followed by 30 cycles of 92°C for
30 sec, 60°C for 30 sec, and 72°C for 30 sec.
2.5. Immunoblotting. To detect protein level changes, 10–
20μg each of cell lysate samples was resolved by SDS-
PAGE and then transferred onto PVDF membranes
(Millipore, Bedford, MA). The membranes were blocked
with 5% bovine serum albumin or 5% nonfat dry milk in 1x
TBS (Tris-buﬀered saline) for 1 hr at room temperature.
Blots were then washed in 1x TBS 0.1% Tween 20 (TBS-T)
(3× for 5min) followed by incubation at 4°C overnight
with primary antibodies as per the manufacturer’s protocols.
Blots then were washed using TBS-T (3× for 10min) and
were incubated with the corresponding secondary HRP-
labelled antibody for 1 hr at RT. Immunocomplexes were
detected by ECL and documented using VersaDOC™
Imaging System (Bio-Rad).
2.6. Antibodies. In this study, the following antibodies were
used to detect the IGF system: phospho-p44/42 MAPK
(#4377), p44/42 MAPK (#9102), phospho-AKT (Ser473,
#4051), and AKT (#9272) (Cell Signaling Technologies,
Burlington, ON) and IGF-1Rα (N-20, sc-712) and IR-α
(N-20, sc-710) (Santa Cruz Biotech., Santa Cruz, CA).
For multipotency markers, we used OCT3/4 antibody
(N-19, sc-8628) (Santa Cruz Biotech., Santa Cruz, CA) and
SOX-2 (2683-1) (Epitomics, Burlington, ON). For the osteo-
genic diﬀerentiation markers, we used RUNX2 (#8486)
(Cell Signaling Technologies, Burlington, ON), phospho-
RUNX2 (PA5-12988) (Thermo Fisher Scientiﬁc, Burlington,
ON), and OPN (K-20, sc-1059) (Santa Cruz Biotech., Santa
Cruz, CA). For the loading control, we used pan-Actin
Ab-5 (#MS-1295) (Thermo Fisher Scientiﬁc, Fremont,
CA). The secondary antibodies used for immunoblotting
were goat anti-rabbit (#170-6515), anti-mouse (#170-6516)
HRP-conjugated antibodies (Bio-Rad Laboratories, Hercules,
CA), or donkey anti-goat antibody (sc-2020) (Santa Cruz
Biotech., Santa Cruz, CA).
2.7. Statistical Analysis. All experiments were run in tripli-
cates from three independent experiments each; whenever
possible, three or more PMSC primary lines were used from
preterm placentae. All graphs and analyses were generated
using GraphPad Prism Software 5.0 (GraphPad Software,
San Diego, CA). A two-way ANOVA with Bonferroni post
hoc test was used for the PMSC WST1 proliferation assay
and densitometry quantiﬁcations. Data are expressed as
mean± standard error of the mean (SEM); values were
considered signiﬁcant when P < 0 05.
3. Results
3.1. Eﬀect of Low Oxygen Tension on PMSC Osteogenic
Diﬀerentiation. In diﬀerentiation conditions, PMSCs had
greater morphological changes over 14 days in room air
by alizarin red staining (Figures 1(a) and 1(b)). Compared
to room air, low oxygen tension stabilized HIF1α and
enhanced cell proliferation at day 14 (Figure S1 available
online at https://doi.org/10.1155/2017/4576327) but inhib-
ited osteogenic diﬀerentiation over the same time period
(Figures 1(a) and 1(b)). Based on quantiﬁcation of staining,
PMSCs showed spontaneous diﬀerentiation into osteogenic-
like cells in room air at day 3 that was inhibited by low oxygen
tension (Figure 1(b)). Therefore, low oxygen tension pre-
vented spontaneous and osteogenic medium-derived diﬀer-
entiation of PMSCs.
To monitor PMSC multipotency and diﬀerentiation,
levels of pluripotency-associated proteins OCT4 and SOX2
and early osteogenic commitment transcription factor
RUNX2 and the later marker OPN were measured at day 3,
7, and 14 (Figure 1(c)). Although PMSCs were under diﬀer-
entiation conditions, OCT4 and SOX2 levels were consis-
tently higher in low oxygen tension compared to room air
(Figure 1(c)). Upon diﬀerentiation at day 14, OCT4 levels
were slightly increased in room air and decreased in low oxy-
gen tension (Figure 1(d)), whereas SOX2 levels were slightly
decreased in room air and low oxygen tension in comparison
to nondiﬀerentiation conditions (Figure 1(e)). RUNX2 levels
were increased upon diﬀerentiation in room air which was
lowered by low oxygen tension (Figure 1(f)). While RUNX2
was robustly increased at day 3 in room air, osteogenic diﬀer-
entiation occurred gradually as demonstrated by OPN
expression, a late marker of diﬀerentiation andmatrix forma-
tion (Figure 1(g)). Again, low oxygen tension inhibited an
increase in OPN levels. Therefore, low oxygen tension
reduced osteogenic diﬀerentiation by maintaining higher
multipotency (higher OCT4 and SOX2) and lowering early
commitment (lower RUNX2) and later diﬀerentiation (lower
OPN) towards the osteogenic lineage.
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Figure 1: PMSC diﬀerentiation under low oxygen tension and its eﬀect on osteogenic diﬀerentiation and multipotency. PMSCs were cultured
for 14 days in nondiﬀerentiation or osteogenic diﬀerentiation conditions containing 15% FBS in room air (20% O2) or low oxygen levels (1%
O2). Treatments were stopped after 1, 3, 7, 10, and 14 days for alizarin red staining to conﬁrm (a) PMSC diﬀerentiation morphology and
quantiﬁed in (b) (two-way ANOVA, P < 0 05, N = 4). ∗ indicates signiﬁcance between room air and low oxygen tension at each time
point; lowercase letter (a, b, and c) indicates signiﬁcance between time points within room air condition, uppercase letter (A, B) indicates
within low oxygen tension. (c) Immunoblots showing protein levels of pluripotency-associated and diﬀerentiation markers from cell
lysates isolated at 3, 7, and 14 days. Quantiﬁcations of day 14 samples show protein levels for (d) OCT4, (e) SOX2, (f) RUNX2, and (g)
OPN in nondiﬀerentiation and diﬀerentiation conditions. Quantiﬁcation levels shown were normalized to β-actin, a protein loading
control (two-way ANOVA, P < 0 05, N = 3). ∗ indicates signiﬁcance between room air and low oxygen tension; # indicates signiﬁcance
between nondiﬀerentiation and diﬀerentiation within the same oxygen tension.
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3.2. Reversibility of the Inhibitory Eﬀect by Low Oxygen
Tension on Osteogenic Diﬀerentiation.We evaluated whether
low oxygen tension irreversibly blocks PMSC diﬀerentiation
by re-exposure to room air following exposure to low oxygen
tension. By introducing PMSCs into room air for the last 7
days of diﬀerentiation, alizarin red staining increased to sim-
ilar levels as in room air (Figures 2(a) and 2(b), left). This
eﬀect was also conﬁrmed by alkaline phosphatase staining,
which was even increased to higher levels than room air
(Figures 2(a) and 2(b), right). Moreover, re-exposure to room
air decreased OCT4 and SOX2 levels in comparison to low
oxygen tension (Figures 2(c) and 2(d) and S2). RUNX2 levels
were also robustly increased upon re-exposure to room air
(Figures 2(e) and S2). These data demonstrate that low
oxygen tension can decrease but does not block osteogenic
diﬀerentiation of PMSCs.
3.3. Eﬀect of Insulin-Like Growth Factors on PMSC Osteogenic
Diﬀerentiation in Low Oxygen Tension. The role of IGFs in
mediating the diﬀerentiation process was investigated by
adding a fresh dose of IGF-1 or IGF-2 (100 ng/mL) with
every medium change for 14 days under room air or low
oxygen tension conditions (Figures 3(a) and 3(b)). In non-
diﬀerentiation conditions, there was an increase in alizarin
red staining indicating an increase in spontaneous diﬀer-
entiation in room air (enhanced at day 7 with IGF-1 and
day 14 with IGF-2) (Figure 3(c)) and less in low oxygen
tension (only at day 3 with both IGFs with no further
increase) (Figure 3(e)). In diﬀerentiation conditions, IGFs
(IGF-1 more than IGF-2) enhanced osteogenic diﬀerentia-
tion morphologically, in both room air and low oxygen
tension, as indicated by increased numbers of calciﬁcation
centers and higher order of cell organization—as shown by
intense alizarin red staining (Figures 3(b) and 3(g)). Inter-
estingly, IGF-1 and IGF-2 in room air enhanced staining
intensity starting at day 3 and reached maximum by day 7,
whereas control (IGF-free conditions) required 14 days to
reach the same level (Figure 3(d)). Low oxygen tension
reduced PMSC diﬀerentiation and inhibited the eﬀects of
IGF-1 or IGF-2 (Figure 3(f)).
The eﬀect of IGFs on PMSC multipotency and diﬀerenti-
ation markers was also determined using immunoblotting
(Figure S3). In room air, IGFs (IGF-2 more than IGF-1)
maintained high OCT4 levels at days 3 and 7, which disap-
peared at day 14 (Figure 4(a), left). In low oxygen tension,
IGFs maintained higher levels of OCT4 throughout diﬀeren-
tiation (Figure 4(a), right). SOX2 was increased only by
IGF-1 at day 3 in room air (Figure 4(b), left). In low oxygen
tension, IGF-1 and IGF-2 maintained lower levels of SOX2
during diﬀerentiation (Figure 4(b), right). In contrast,
RUNX2 was increased by IGF-1 and IGF-2 in the early stages
of diﬀerentiation (day 3) and was maintained at higher levels
only by IGF-1 at day 14 (Figure 4(c), left). Low oxygen ten-
sion abolished this IGF-1 eﬀect on RUNX2 (Figure 4(c),
right). However, it seems that the IGF-1 eﬀect on increasing
RUNX2 levels is delayed by low oxygen tension, in the
preconditioning study after the exposure to room air (Figure
S2). OPN increased by day 14 in room air in the absence of
IGFs (Figure 4(d), left), whereas IGF-1 increased OPN levels
at day 7 and further increased at day 14 only in room air
(Figure 4(d), left). On the other hand, IGF-2 was opposite
to IGF-1 and caused a reduction in OPN levels. Low oxygen
tension inhibited any increase in OPN levels and also pre-
vented the IGF-1-mediated increase shown in room air
(Figure 4(d), right). These data support that IGF-1 has an
important role in osteogenic diﬀerentiation, and higher oxy-
gen tension is needed to promote osteogenic diﬀerentiation.
3.4. Role of Insulin-Like Growth Factor Receptors in PMSC
Osteogenic Diﬀerentiation under Low Oxygen Tension.
IGF-1 and IGF-2 can signal via the insulin-like growth
factor-1 receptor (IGF-1R) or the insulin receptor (IR) to
promote proliferation and diﬀerentiation. In room air,
IGF-1R did not change upon diﬀerentiation and was not
aﬀected by IGFs, whereas IR was increased in diﬀerentiating
PMSCs and upregulated by IGF-1 (Figures 6(a), 6(b), and
6(c)). In low oxygen tension, the IGF-1R was increased in dif-
ferentiation conditions but reduced by both IGF-1 and IGF-2
(Figure 5(b), right), whereas no change in IR was observed in
diﬀerentiation conditions (Figure 5(c)). IR exists in two
isoforms, IR-A and IR-B, which can determine the diﬀer-
entiation status of stem cells. A higher ratio of IR-B : IR-A
possibly suggests a more diﬀerentiated state towards the oste-
ogenic lineage. In PMSCs, IR-B : IR-A ratio was low in non-
diﬀerentiated PMSCs (Figure 6(d)). Upon diﬀerentiation,
the level of IR-B : IR-A increased gradually in room air but
not in low oxygen tension (Figure 6(e)). This was caused by
the elevated expression of IR-A than of IR-B in low oxygen
tension (Figure S4, right). IGF-1 or IGF-2 increased the IR-
B : IR-A ratio earlier at day 3 that was reduced at days 7 and
14 in room air, unlike the consistent lower ratio in low
oxygen tension (Figures 6(f) and 6(g)).
3.5. Downstream Insulin-Like Growth Factor Signaling
Mediates Osteogenic Diﬀerentiation. Downstream kinases of
IGF receptor signaling, p-ERK1/2 and p-AKT, are major sig-
naling kinases to mediate an IGF eﬀect. In PMSCs, p-ERK1/2
decreased gradually over the diﬀerentiation process in room
air, while it was maintained higher in low oxygen tension at
days 3 and 7 (Figure 5(a)). A signiﬁcant decrease in ERK1/2
levels was detected at day 14 regardless of oxygen tension.
The addition of IGF-1 or IGF-2 caused a further reduction
in p-ERK1/2 levels in room air and low oxygen tension
(Figure 5(a)). p-AKT was not signiﬁcantly changed in room
air and even in the presence of IGFs (Figure 5(b), left). On
the other hand, IGF-1 increased the levels of p-AKT in low
oxygen tension during diﬀerentiation (Figure 5(b), right).
During osteogenic diﬀerentiation, RUNX2 is phosphorylated
by MAPK (MEK1/2), which can aﬀect its DNA binding and
protein-protein interactions. Only in room air, p-RUNX2
levels were elevated at day 14 in the absence of IGFs, whereas
the addition of IGF-1 or IGF-2 increased p-RUNX2 levels to
~8 and ~4 folds, respectively (Figure 5(c), left). In low oxygen
tension, RUNX2 phosphorylation was not upregulated
throughout the diﬀerentiation (Figure 5(c), right).
To specify the role of signaling kinases in mediating
PMSC diﬀerentiation, U0126 and LY294002 were used to
inhibit MEK1/2 and PI3K, the upstream kinases of ERK1/2
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Figure 2: Eﬀect of low oxygen tension preconditioning on PMSC osteogenic diﬀerentiation and multipotency. PMSCs were cultured in
nondiﬀerentiation or osteogenic diﬀerentiation conditions containing 15% FBS in room air (20% O2) or low oxygen levels (1% O2) for 14
days as in Figure 1. For low/room treatment, PMSCs were cultured for 7 days in low oxygen and followed by 7 days in room air (shown
in the third panel). Alizarin red or alkaline phosphatase staining was used to detect calcium deposition and enzyme expression changes as
shown morphologically in (a) and quantiﬁed in (b) (two-way ANOVA, P < 0 05, N = 4); lowercase letter (a, b, and c) indicates signiﬁcance
between oxygen tension eﬀects within nondiﬀerentiation condition, uppercase letter (A, B, C) indicates within diﬀerentiation conditions.
From immunoblots shown in Figure S2, protein levels were quantiﬁed in (c) OCT4, (d) SOX2, and (e) RUNX2 levels. Quantiﬁcation levels
shown were normalized to β-actin, a protein loading control (two-way ANOVA, P < 0 05, N = 3). ∗ indicates signiﬁcance between room
air and low oxygen tension; lowercase letter (a, b, and c) indicates signiﬁcance between oxygen tension eﬀects within nondiﬀerentiation
condition, uppercase letter (A, B, and C) indicates within diﬀerentiation conditions.
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Figure 3: PMSC diﬀerentiation under low oxygen tension is regulated by IGFs. PMSCs were cultured in nondiﬀerentiation or diﬀerentiation
conditions containing 2% FBS in the presence or absence of 100 ng/mL of IGF-1 or IGF-2, in room air (20% O2) or low oxygen levels (1% O2).
Treatments were stopped after 3, 7, and 14 days for (a-b) alizarin red staining and quantiﬁed in (c-d) (two-way ANOVA, P < 0 05, N = 4). X
indicates signiﬁcance between diﬀerent days without IGFs; # indicates signiﬁcance of IGF addition compared with no IGFs in the same day. (g)
Calciﬁcation centers and cell organization of diﬀerentiated PMSCs stained with alizarin red from day 14 are shown in higher magniﬁcation.
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Figure 4: Continued.
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and AKT, respectively. After 14 days, the alizarin red staining
was reduced more by LY294002 than by U0126 (Figures 7(a)
and 7(b)) without aﬀecting PMSC viability (Figure S5).
U0126 did not change the levels of OCT4 and SOX2 in
diﬀerentiating PMSCs (Figures 7(c) and 7(d)); however,
RUNX2 and OPN were increased in low oxygen tension
(Figures 7(e) and 7(f)). This demonstrates that the
repression of osteogenic diﬀerentiation by low oxygen
tension may be mediated by MEK1/2 signaling. LY294002
reduced OCT4, SOX2, RUNX2, and OPN in diﬀerentiation
conditions but more so in low oxygen tension (Figures 7(c),
7(d), 7(e), and 7(f)). Therefore, PI3K signaling has a dual
role in PMSCs—to maintain multipotency and to promote
osteogenic diﬀerentiation.
The eﬀects of the inhibitors were assessed by phos-
phorylation of ERK1/2 and AKT. The addition of U0126
and LY294002 every 48 hours reduced phosphorylation
of ERK1/2 and AKT (Figure S6), respectively. At day 14
of diﬀerentiation, U0126 decreased p-ERK1/2 levels in
room air and not in low oxygen tension (Figure 7(g)).
LY294002 inhibited AKT phosphorylation in room air and
even lower in low oxygen tension conditions (Figure 7(h)),
yet LY294002 increased p-ERK1/2 levels in low oxygen
tension (Figure 7(g)). RUNX2 phosphorylation was unaf-
fected with U0126 in room air but was decreased with
LY294002 (Figure 7(i)). In low oxygen tension, p-RUNX2
was increased only with U0126 during diﬀerentiation
(Figure 7(i)). Therefore, the balance of MEK1/2 and PI3K
signaling is required to mediate osteogenic diﬀerentiation,
especially in low oxygen tension, as their misregulation can
cause PMSC diﬀerentiation.
4. Discussion
The successful use of stem cells for cell-based therapies
requires an optimization of stem cell survival and potency
in vitro, preventing cell death in vivo postinjection [41].
In this study, we used low oxygen tension and IGFs to
determine their combined eﬀect on the commitment
and diﬀerentiation of PMSCs towards the osteogenic lin-
eage (Figure 8). We found that low oxygen tension
increased PMSC proliferation, induced higher OCT4 and
SOX2 levels, blocked diﬀerentiation and mineralization,
and reduced the IGF-mediated early onset of osteogenic
diﬀerentiation. Low oxygen tension also increased the
levels of IGF-1R in diﬀerentiated PMSCs. In comparison,
insulin receptor expression was increased in room air
with an elevated IR-B, opposite to IR-A which was
enhanced by low oxygen tension. Upon diﬀerentiation,
RUNX2 levels were increased with loss of pluripotency-
associated proteins. Only in room air, RUNX2 was
phosphorylated and enhanced by IGF-1 and IGF-2 which
may explain the more robust osteogenic diﬀerentiation level.
In vitro, osteogenic diﬀerentiation follows a three-phase
process: a diﬀerentiation phase (days 0–5), a matrix forma-
tion phase (days 5–12), and a mineralization phase (days
12–19) [37]. In this study, we investigated the role of IGFs
in combination of low oxygen tension in the commitment
and matrix formation phases of PMSC diﬀerentiation
(days 0–14). In this process, RUNX2 is strongly detected
in preosteoblasts, immature osteoblasts, and early osteo-
blasts [18, 42]. We demonstrated that RUNX2 is expressed
in early diﬀerentiation in room air and inhibited by low
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Figure 4: PMSC multipotency and diﬀerentiation are regulated under low oxygen tension by IGFs. PMSCs were cultured for 14 days in
osteogenic diﬀerentiation conditions containing 2% FBS in the presence or absence of 100 ng/mL of IGF-1 or IGF-2 in room air (20% O2)
or low oxygen levels (1% O2). Treatments were stopped after 3, 7, and 14 days. Immunoblots, shown in Figure S3, were used to quantify
the changes in protein levels of (a) OCT4, (b) SOX2, (c) RUNX2, and (d) OPN induced by IGFs over time. Quantiﬁcation levels were
normalized to β-actin, a protein loading control (two-way ANOVA, P < 0 05, N = 3). X indicates signiﬁcance between diﬀerent days
without IGFs; # indicates signiﬁcance of IGF addition compared with no IGFs in the same day.
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oxygen tension. OPN, as a late osteogenic diﬀerentiation
marker, was also repressed by low oxygen tension. IGFs
enhanced PMSC diﬀerentiation only in room air (IGF-1
has a greater eﬀect than IGF-2) where low oxygen tension
abolished their eﬀect. Previously, IGF-1 was shown to
increase the levels of RUNX2 [26], and similarly in
PMSCs, IGF-1 and IGF-2 increased RUNX2 levels as early
as day 3 and maintained elevated levels at day 14. Also,
OPN was elevated as early as day 7 with IGF-1, which
increased further at day 14.
IGFs enhance the diﬀerentiation function by promoting
growth, inhibiting apoptosis, and upregulating matrix matu-
ration (increased type I collagen) and mineralization [36]. In
vivo, the use of MSCs that overexpress IGF-1 improves
fracture healing by accelerating bone cell diﬀerentiation
[43]. Signaling through IGF-1R in MSCs during diﬀerentia-
tion is regulated by PI3K/AKT and not by MAPK signaling
(in a positive feedback loop) which also inhibits apoptosis
in osteoblasts [29, 43]. In this study, we showed that the
inhibition of PI3K caused a signiﬁcant reduction in the
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Figure 5: Eﬀect of oxygen tension and IGF-1 or IGF-2 on signaling downstream kinases of cell surface receptors during osteogenic
diﬀerentiation. Similar to Figures 4 and 6, PMSCs were cultured for 14 days in osteogenic diﬀerentiation conditions containing 2% FBS in
the presence or absence of 100 ng/mL of IGF-1 or IGF-2 in room air (20% O2) or low oxygen levels (1% O2). Treatments were stopped
after 3, 7, and 14 days. Immunoblots, in Figure S3, were used to quantify protein levels of (a) p-ERK1/2, (b) p-AKT, and (c) p-RUNX2
over the three days. These kinases/phosphoproteins were normalized to their total kinase/phosphoprotein level and β-actin (two-way
ANOVA, P < 0 05, N = 3). X indicates signiﬁcance between diﬀerent days without IGFs; # indicates signiﬁcance of IGF addition compared
with no IGFs in the same day; ∗ indicates signiﬁcance between room air and low oxygen tension.
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Figure 6: IGF-1R and IR levels and its isoforms (IR-A and IR-B) in diﬀerentiating PMSCS are regulated by oxygen tension and IGFs. PMSCs
were cultured for 14 days in nondiﬀerentiation or osteogenic diﬀerentiation conditions containing 2% FBS in the presence or absence of
100 ng/mL of IGF-1 or IGF-2 in room air (20% O2) or low oxygen levels (1% O2). Treatments were stopped after 3, 7, and 14 days.
Immunoblots were used to detect levels of (a) IGF-1R and IR in the absence of IGFs over time. Quantiﬁcation of immunoblots, shown in
Figure S3, shows the IGF-1 or IGF-2 eﬀect on (b) IGF-1R and (c) IR over the three days. Levels were normalized to β-actin, a protein
loading control (two-way ANOVA, P < 0 05, N = 3). X indicates signiﬁcance between diﬀerent days without IGFs; # indicates signiﬁcance
of IGF addition compared with no IGFs in the same day. By end-point PCR, mRNA levels of IR-A versus IR-B were measured and a ratio
was calculated and normalized to total IR in (d) undiﬀerentiated day 0 PMSCs, (e) diﬀerentiation without IGFs, (f) diﬀerentiation with
IGF-1, and (g) diﬀerentiation with IGF-2 (two-way ANOVA, P < 0 05, N = 3). ∗ indicates signiﬁcance between room air and low oxygen
tension; lowercase letter (a, b) indicates signiﬁcance between time points within room air condition, uppercase letter (A) indicates within
low oxygen tension.
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multipotency markers (OCT4 and SOX2) and the osteogenic
markers (RUNX2 and OPN) supporting that PI3K is
required not only to maintain multipotency but also to regu-
late PMSC diﬀerentiation.
RUNX2 exerts its transcriptional activity via binding to
its cognate DNA site in promoter regions of osteogenic dif-
ferentiation genes (such as, OCN and OPN) [44]. RUNX2
is phosphorylated by the MEK/ERK pathway in vitro [20]
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Figure 7: PMSC diﬀerentiation is mediated via MEK1/2 and PI3K signaling and their inhibition eﬀect on ERK1/2, AKT, and RUNX2
phosphorylation under low oxygen tension. PMSCs were cultured for 14 days in osteogenic diﬀerentiation conditions containing 2% FBS
in room air (20% O2) or low oxygen levels (1% O2). During the 14 days, cells were continuously exposed to (5 μM) U0126 or (10 μM)
LY294002 in diﬀerentiation media. Treatments were stopped at 14 days and stained with alizarin red to conﬁrm (a) PMSC diﬀerentiation
morphology changes with the inhibitors and quantiﬁed in (b) (two-way ANOVA, P < 0 05, N = 4). Immunoblots, shown in Figure S7,
were used to quantify protein levels of (c) OCT4, (d) SOX2, (e) RUNX2, (f) OPN, (g) p-ERK1/2, (h) p-AKT, and (i) p-RUNX2 induced by
signaling inhibition. Quantiﬁcation levels were normalized to β-actin, a protein loading control; additionally, each phosphoprotein was
normalized to its total protein (two-way ANOVA, P < 0 05, N = 3). ∗ indicates signiﬁcance between room air and low oxygen tension;
# indicates signiﬁcance between DMSO control and inhibitor.
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and in vivo [45] which triggers its transcriptional activity. In
PMSCs, IGF-1 and IGF-2 increased the phosphorylation of
RUNX2 at day 14 of PMSC diﬀerentiation, thereby enhanc-
ing diﬀerentiation and osteogenic gene transcription. These
data demonstrate that IGF-1, more than IGF-2, is a potent
growth factor required by PMSCs to complete the diﬀerenti-
ation process. In bone marrow MSCs, FGF2 signaling via
MEK/ERK was shown to induce RUNX2 phosphorylation
that activates an OCN promoter [21]. Also, in HBME cells,
IGF-1 induced the RUNX2 DNA binding activity by the
MEK/ERK pathways in a sequential activation process [46].
Therefore, the MAPK pathway connects between the cell
surface receptor signaling (e.g., IGF-1R) and RUNX2 phos-
phorylation to advance osteogenic diﬀerentiation. On the
contrary, one report showed that MEK1/2 signaling is
suppressive for osteoprogenitor diﬀerentiation in a neuro-
ﬁbromatosis type I mouse model [47], indicating that
inhibition of MEK1/2 signaling is required for osteogenic
diﬀerentiation. Interestingly, MEK1/2 inhibition elevated
total and phosphorylated levels of RUNX2 and OPN in
PMSCs in low oxygen tension; however, it could not res-
cue mineralization. Therefore, MEK1/2 signaling can be
oxygen tension dependent that may repress osteogenic
diﬀerentiation in low oxygen tension by lowering RUNX2
and OPN levels.
The transcriptional network of OCT4 and SOX2 in main-
taining pluri-/multipotency and repressing diﬀerentiation
has been shown in mouse and human embryonic stem cells.
In mESCs, mesodermal lineage speciﬁcation is determined
by OCT4 and SOX2: a balanced expression maintains pluri-
potency, while the upregulation of OCT4 relative to SOX2
induces mesendodermal lineage speciﬁcation and downregu-
lation of OCT4 relative to SOX2 induces neural ectodermal
lineage speciﬁcation [48, 49]. In human ESCs, OCT4 main-
tains an embryonic stem cell state and represses extraembry-
onic diﬀerentiation, while SOX2 is required to suppress the
diﬀerentiation towards the mesendodermal [50]. In PMSCs,
osteogenic diﬀerentiation increased the expression of OCT4
and decreased the expression of SOX2, as expected in a meso-
dermal diﬀerentiating lineage, only when placed in room air.
Low oxygen tension upregulated both OCT4 and SOX2
maintaining a more multipotent state even under diﬀerentia-
tion conditions, similar to a previous study [51]. Also, we
observed that diﬀerentiating PMSCs upregulated OCT4 prior
to diﬀerentiation, which could be important for facilitating
diﬀerentiation. In fact, in ESCs, OCT4 was required for
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Figure 8: PMSC osteogenic diﬀerentiation in the presence of IGFs and low oxygen tension. Summary diagram showing stem cell
diﬀerentiation model in room air versus low oxygen. PMSCs can diﬀerentiate into osteogenic lineage only in room air, while maintaining
PMSCs in low oxygen tension impedes this diﬀerentiation process. (A) In low oxygen tension, nondiﬀerentiation conditions maintain self-
renewal (higher proliferation) and IGF-2 can maintain higher expression of OCT4 and SOX2. (B) In diﬀerentiation media, PMSCs show
an impeded diﬀerentiation with higher OCT4 and SOX2 and lowered RUNX2, which recovers following room air exposure. (C) In room
air, spontaneous diﬀerentiation occurs with lower OCT4 and SOX2 and lower RUNX2. (D) In diﬀerentiation media, PMSCs fully
diﬀerentiate towards osteoblastic progenitors with higher RUNX2 and OPN, which enhanced by IGF-1. Cell morphology and alizarin red
staining increase as PMSCs lose multipotency and commit to the osteogenic lineage.
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in vivo and in vitro diﬀerentiation processes and OCT4-
deﬁcient cells were unable to diﬀerentiate [52].
Oxygen tension is increasingly recognized as an impor-
tant factor of the stem cell niche in proliferation, migration,
metabolism, and diﬀerentiation. In bone fractures, oxygen
level can go as low as 0.1% (~0.76mmHg) [37, 53]. Also,
oxygen tension at the fracture site of the femoral head can
be low at 17.3–19.9mmHg and even lower at 1 cm away
from fracture site (12.5–12.8mmHg) [54]. The hypoxia-
inducible factor (HIF) system is responsible for downregu-
lating the expression of osteoblast commitment genes, such
as RUNX2 [37], and a complete diﬀerentiation is obscured
due to inhibiting the expression of downstream genes
responsible for mineralization and matrix formation
(OPN and OCN) [37]. However, few contradicting reports
have shown that low oxygen tension may favour osteogenic
diﬀerentiation and mineralization of MSCs which was
referred to be dependent on the oxygen tension used during
stem cell expansion following initial isolation [55]. Another
report also argues that mineralization occurs in low oxygen
tension; however, RUNX2 and alkaline phosphatase levels
were reduced, compared with those in room air [56]. In
this study, low oxygen tension impeded the complete diﬀer-
entiation and calciﬁcation of PMSCs, but RUNX2 levels
were elevated compared with those in nondiﬀerentiation
conditions. This inhibition was reversed upon exposure to
higher oxygen tension as was demonstrated by the elevated
alkaline phosphatase staining levels compared with room
air (Figure 2). Indeed, stem cell preconditioning was shown
to improve healing and survival of fractured bone following
transplantation [34]. The inhibition of diﬀerentiation by
low oxygen tension (with stabilized HIF1α) inhibits a met-
abolic switch required for osteogenic diﬀerentiation [57],
which relies on the upregulation of mitochondrial function
and aerobic respiration (with downregulation of HIF1α)
[58]. Therefore, glycolysis in undiﬀerentiated MSCs is not
suﬃcient for ATP production, as diﬀerentiating MSCs
switch to oxidative phosphorylation to meet the high
energy demand of diﬀerentiation processes, matrix deposi-
tion, and mineralization [57].
Low oxygen tension inhibited the enhanced IGF-
mediated osteogenic diﬀerentiation in PMSCs, which can
be due to ligand/receptor signaling downregulation. In a pre-
vious report, we noticed that low oxygen tension upregulates
the levels of IGF-1R and IR [59]; therefore, it is possible that
IGF ligands are obscured from the receptors. IGF-binding
proteins (IGFBPs), such as IGFBP-1 and IGFBP-3, are
upregulated by low oxygen tension, and their binding
aﬃnity to IGFs can block the interaction between IGFs
and their receptors [60, 61]. A recent report demonstrated
by siRNA studies that the upregulation of hypoxia-
responsive IGFBP-3 in adipose-derived and bone marrow
stem cells reduced their osteogenic diﬀerentiation and min-
eralization in low oxygen tension [62]. Also in PMSCs,
IGFBP-3 is upregulated by low oxygen tension (data not
shown), and therefore, it may bind to IGF-1 and inhibit its
actions via the IGF-1R activation, abolishing the IGF-1-
induced osteogenic diﬀerentiation presented in room air.
This mechanism needs to be investigated.
IGF-1R and IR signaling pathways are indispensable for
postnatal bone growth and turnover. In patients with osteo-
porosis, primary osteoblasts have an impaired IGF-1R signal-
ing decoupled from IGF-1 stimulation [63], which causes
lower proliferation rate and diﬀerentiation and therefore
bone loss. In insulin-dependent diabetic patients, the low
insulin levels can lead to osteopenia, increased risk of fragility
fracture, and poor bone healing [64, 65]. In mice, the knock-
out of IGF-1R in osteoblasts causes a reduced trabecular bone
volume with defective mineralization [66]. On the other
hand, mice lacking the IR in osteoblasts have reduced trabec-
ular bone; however, unlike IGF-1R knockouts, bone was nor-
mally mineralized [67]. Hence, IGF-1R signaling is essential
for coupling matrix biosynthesis to sustain mineralization.
Indeed, IGF-1R or IR presence aﬀects osteoblast number/
abundance in bone, in which the absence of IGF-1R does
not change the number of osteoblasts but the knockdown
of IR severely reduces the number of osteoblasts in bone
[66, 67]. Interestingly, conditional knockdown of IGF-1R
from osteoblasts greatly increases their insulin responsive-
ness via the IR which can partially compensate for the IGF-
1R by promoting proliferation and mineralization [68]. Even
though the IR can compensate for IGF-1R loss, the IGF-1R is
essential for augmenting these signaling interactions for nor-
mal bone growth and turnover. Between the two IR isoforms,
IR-B is abundantly expressed in diﬀerentiating MSCs and
mature osteoblasts while IR-A was abundantly expressed in
proliferating cells [69]. Therefore, the IR increases with a
higher ratio of IR-B to IR-A in diﬀerentiating osteoblasts
[69]. In our PMSCs, we showed that the IR-A is elevated by
low oxygen tension in diﬀerentiation conditions; however,
IR-B was the dominant isoform in room air. Unlike IR-A,
which mediates mitogenic actions involved in increased cell
proliferation, atherosclerosis, and cancer, IR-B is responsible
for metabolic action to facilitate metabolism, cell diﬀerentia-
tion, and increased longevity [70]. This suggests that diﬀer-
entiating osteoblasts express higher IR-B levels to utilize
more glucose for metabolism and possibly to accommodate
the higher energy demand in diﬀerentiating cells.
In summary, we have shown in this study that PMSCs
can successfully diﬀerentiate towards the osteogenic lineage;
thus, they may be an alternative source to bone marrow
for adult MSCs. Preconditioning in low oxygen tension
and the use of IGFs (mainly IGF-1) to stimulate PMSCs
are promising strategies to generate osteogenic progenitor
cells for tissue regeneration therapy in bone diseases and
repair. Further, in vivo studies in animal models using
these strategies will be required to determine the successful
engraftment of PMSCs for the regenerative therapy in OI
or bone fractures.
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